Modern Slush Slashes Costs


Supplies More Procedures


NEWSWIRE


ing poster submissions of projects related to the sterile processing industry. This year’s event offers a new opportunity for presenting posters LIVE at the confer- ence, if selected. Live presentations are not mandatory and will be selected by IAHCSMM. Posters may highlight a wide range of SP-related successes -- from quality im- provement, cost savings or patient safety initiatives to infection prevention, staff development and customer relations improvements. Submissions:


 Attendee Posters must be non-com- mercial;


 endor Posters may contain commercial information, but must have an educa- tional (not sales) focus;


 Submissions should contain only origi- nal material, not published or presented elsewhere prior to submission;


 Posters must be submitted as a single high resolution image, or as a nine-slide PowerPoint Presentation;


SurgiSLUSHTM Auto-Freezer


 All poster submissions must be received no later than 11:59pm CST, Friday, Janu- ary 31, 2020; and


 All entries must be submitted online. Posters submitted via fax or email will not be accepted. Incomplete submis- sions and posters submitted after this deadline will not be considered. Early bird registration for the conference is open through Tuesday, Dec. 31, 2019.


Protective Container System


TM SurgiSLUSH TM Auto-Freezers


Automates Expert Slush


Save with SurgiSLUSH


TM


Hospitals recognized for meritorious surgical patient care outcomes The American College of Surgeons’ (ACS) National Surgical Quality Improvement Program (ACS NSQIP) has recognized 88 of an eligible 592 hospitals participat- ing in the adult program for achieving meritorious outcomes for surgical patient care in 2018.


°C Change S U R G I C A L


E-mail info@cchangesurgical.com Toll-free (877) 989-3737


www.cchangesurgical.com HealthTrust Contract #12318


Visit www.ksrleads.com/?912hp-013 8 December 2019 • HEALTHCARE PURCHASING NEWS • hpnonline.com


ACS NSQIP participating hospitals are required to track the outcomes of inpatient and outpatient surgical procedures; these outcomes are then analyzed by ACS and reported back to hospitals. These results direct patient safety initiatives within the hospital and impact the quality of surgi- cal care.


The ACS NSQIP recognition program commends a select group of hospitals for achieving a meritorious composite score in either an “All Cases” category or a category which includes only “High Risk” cases. Each composite score was determined through a different weighted formula combining eight outcomes. Out- comes in the following eight clinical areas were evaluated:


 Mortality  Cardiac (cardiac arrest and myocardial infarction)  Pneumonia


 Unplanned Intubation  entilator  48 hours  enal ailure  SSI: superfi cial incisional SSI, deep inci- sional SSI, and organ/space SSI  UTI (urinary tract infection) To be eligible for either list, the hospital must have submitted at least one case in each of the calendar years, 2016, 2017, and 2018, though only performance in calendar year 2018 was evaluated for the 2018 meritorious lists. Five hundred and ninety-two of the 722 NSQIP hospitals participating in 2018 met the three-year criteria to be eligible for Meritorious consideration.


FDA Ethylene Oxide sterilization facility updates The Food and Drug Administration is closely monitoring the supply chain ef- fects of closures and potential closures of certain facilities that use ethylene oxide to sterilize medical devices prior to their use. The agency is concerned about the future availability of sterile medical devices and the potential for medical device shortages that might impact patient care.


Additionally, the FDA is working with


device manufacturers and healthcare delivery organizations to ensure they are aware of the issues and preparing to reduce the patient impact if medical devices sterilized at these sterilization facilities become unavailable. Medical devices that are sterilized to remove potentially harmful germs and other microorganisms prior to use are critical to our healthcare system and a shortage — especially of life-saving, life- sustaining, or critical devices — and can present a risk to public health. Healthcare providers and consumers: The FDA encourages healthcare provid- ers, healthcare delivery organizations, and the public to email the FDA’s device shortages mailbox (deviceshortages@fda. hhs.gov) if they are encountering any de- vice availability challenges and/or have concerns with the adequacy of medical devices to meet patient needs. Device manufacturers: The FDA re- minds device manufacturers to email the FDA’s device shortages mailbox (devic- eshortages@fda.hhs.gov) if they would be impacted by the potential closure of the BD contract sterilization facility and an- ticipate delays in distribution of devices to their customers as a result. HPN


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54